Hebei Changshan Biochem Pharma (300255) — Cash Flow Reinvestment Rate
Hebei Changshan Biochem Pharma (300255) has a Cash Flow Reinvestment Rate of 0.53x as of June 2025, reinvesting CN¥37.29 Million (capex CN¥18.63 Million plus investments CN¥-18.66 Million) from operating cash flow of CN¥70.22 Million. Explore Hebei Changshan Biochem Pharma capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hebei Changshan Biochem Pharma Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Hebei Changshan Biochem Pharma across 10 annual periods. Also explore 300255 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year capital reinvestment analysis for Hebei Changshan Biochem Pharma. For live market cap and broader valuation context, see 300255 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 8.42x | CN¥473.35 Million | CN¥56.22 Million | CN¥239.59 Million | ▼ -40.6% |
| 2023 | 14.18x | CN¥478.17 Million | CN¥33.73 Million | CN¥239.32 Million | ▼ -94.9% |
| 2022 | 275.97x | CN¥862.55 Million | CN¥3.13 Million | CN¥431.22 Million | ▲ +28.8% |
| 2021 | 214.31x | CN¥615.39 Million | CN¥2.87 Million | CN¥308.08 Million | ▲ +26150.7% |
| 2018 | 0.82x | CN¥239.05 Million | CN¥292.81 Million | CN¥234.85 Million | ▼ -46.2% |
| 2017 | 1.52x | CN¥246.30 Million | CN¥162.28 Million | CN¥158.30 Million | ▼ -39.5% |
| 2016 | 2.51x | CN¥431.24 Million | CN¥171.96 Million | CN¥96.52 Million | ▲ +40.5% |
| 2011 | 1.79x | CN¥30.43 Million | CN¥17.04 Million | CN¥30.43 Million | ▲ +39.0% |
| 2010 | 1.28x | CN¥37.56 Million | CN¥29.25 Million | CN¥37.56 Million | ▲ +29.3% |
| 2009 | 0.99x | CN¥24.05 Million | CN¥24.21 Million | CN¥24.05 Million | — |